Cost-effective recruitment methods for a large randomised trial in people with diabetes: A Study of Cardiovascular Events iN Diabetes (ASCEND).
Clinical trials require cost-effective methods for identifying, randomising, and following large numbers of people in order to generate reliable evidence. ASCEND (A Study of Cardiovascular Events iN Diabetes) is a randomised '2 × 2 factorial design' study of aspirin and omega-3 fatty acid...
Main Authors: | Aung, T, Haynes, R, Barton, J, Cox, J, Murawska, A, Murphy, K, Lay, M, Armitage, J, Bowman, L, ASCEND Study Collaborative Group |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2016
|
Similar Items
-
ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
by: Bowman, L, et al.
Published: (2017) -
Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
by: Sarah Parish, et al.
Published: (2023-03-01) -
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
by: Parish, S, et al.
Published: (2022) -
Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial
by: Aung, T, et al.
Published: (2017) -
Effects of n-3 fatty acid supplements in diabetes mellitus
by: Ascend Study Collaborative Group, et al.
Published: (2018)